Pedro J. Batista

Dr. Pedro J. Batista


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Cell
Verified
Journal Article
Closed access
RFRyan A. Flynn
Ryan A. Flynn
KPKayvon Pedram
Kayvon Pedram
SMStacy Malaker
Stacy Malaker
PBPedro J. Batista
Pedro J. Batista
BSBenjamin A.H. Smith
Benjamin A.H. Smith
CBCarolyn Bertozzi
Carolyn Bertozzi

31 October 2017 in eLife
Verified
Journal Article
Open access
ABAlexis S Bailey
Alexis S Bailey
PBPedro J. Batista
Pedro J. Batista
RGRebecca S Gold
Rebecca S Gold
YCY Grace Chen
Y Grace Chen
Dirk G. de RooijDirk G. de Rooij
Dirk G. de Rooij
MFMargaret T Fuller
Margaret T Fuller
The switch from mitosis to meiosis is the key event marking onset of differentiation in the germline stem cell lineage. In Drosophila, the translational repressor Bgcn is required for spermatogonia to stop mitosis and transition to meiotic prophase and the spermatocyte state. Here we show that the mammalian Bgcn homolog YTHDC2 facilitates a clean switch from mitosis to meiosis in mouse germ cells, revealing a conserved role for YTHDC2 in this critical cell fate transition. YTHDC2-deficient male germ cells enter meiosis but have a mixed identity, maintaining expression of Cyclin A2 and failing to properly express many meiotic markers. Instead of continuing through meiotic prophase, the cells attempt an abnormal mitotic-like division and die. YTHDC2 binds multiple transcripts including Ccna2 and other mitotic transcripts, binds specific piRNA precursors, and interacts with RNA granule components, suggesting that proper progression of germ cells through meiosis is licensed by YTHDC2 through post-transcriptional regulation.

19 May 2017 in Genomics, Proteomics & Bioinformatics
Verified
Journal Article
Open access
PBPedro J. Batista
Pedro J. Batista
Impaired gene regulation lies at the heart of many disorders, including developmental diseases and cancer. Furthermore, the molecular pathways that control gene expression are often the target of cellular parasites, such as viruses. Gene expression is controlled through multiple mechanisms that are coordinated to ensure the proper and timely expression of each gene. Many of these mechanisms target the life cycle of the RNA molecule, from transcription to translation. Recently, another layer of regulation at the RNA level involving RNA modifications has gained renewed interest of the scientific community. The discovery that N6-methyladenosine (m6A), a modification present in mRNAs and long noncoding RNAs, can be removed by the activity of RNA demethylases, launched the field of epitranscriptomics; the study of how RNA function is regulated through the addition or removal of post-transcriptional modifications, similar to strategies used to regulate gene expression at the DNA and protein level. The abundance of RNA post-transcriptional modifications is determined by the activity of writer complexes (methylase) and eraser (RNA demethylase) proteins. Subsequently, the effects of RNA modifications materialize as changes in RNA structure and/or modulation of interactions between the modified RNA and RNA binding proteins or regulatory RNAs. Disruption of these pathways impairs gene expression and cellular function. This review focuses on the links between the RNA modification m6A and its implications in human diseases.

6 August 2020 in Nature Reviews Genetics
Verified
Journal Article
Closed access
PDF file
DZDali Zong
Dali Zong
POPhilipp Oberdoerffer
Philipp Oberdoerffer
PBPedro J. Batista
Pedro J. Batista
ANAndré Nussenzweig
André Nussenzweig

1 March 2019 in Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
Verified
Journal Article
Closed access
CFChristina M. Fitzsimmons
Christina M. Fitzsimmons
PBPedro J. Batista
Pedro J. Batista

9 January 2024 in NAR Cancer
Verified
Journal Article
Open access
PDF file
CFChristina M Fitzsimmons
Christina M Fitzsimmons
MMMariana D Mandler
Mariana D Mandler
JLJudith C Lunger
Judith C Lunger
DCDalen Chan
Dalen Chan
SMSiddhardha S Maligireddy
Siddhardha S Maligireddy
PBPedro J. Batista
Pedro J. Batista
Metabolic reprogramming is a hallmark of cancer that facilitates changes in many adaptive biological processes. Mutations in the tricarboxylic acid cycle enzyme fumarate hydratase (FH) lead to fumarate accumulation and cause hereditary leiomyomatosis and renal cell cancer (HLRCC). HLRCC is a rare, inherited disease characterized by the development of non-cancerous smooth muscle tumors of the uterus and skin, and an increased risk of an aggressive form of kidney cancer. Fumarate has been shown to inhibit 2-oxoglutarate-dependent dioxygenases (2OGDDs) involved in the hydroxylation of HIF1α, as well as in DNA and histone demethylation. However, the link between fumarate accumulation and changes in RNA post-transcriptional modifications has not been defined. Here, we determine the consequences of fumarate accumulation on the activity of different members of the 2OGDD family targeting RNA modifications. By evaluating multiple RNA modifications in patient-derived HLRCC cell lines, we show that mutation of FH selectively affects the levels of N6-methyladenosine (m6A), while the levels of 5-formylcytosine (f5C) in mitochondrial tRNA are unaffected. This supports the hypothesis of a differential impact of fumarate accumulation on distinct RNA demethylases. The observation that metabolites modulate specific subsets of RNA-modifying enzymes offers new insights into the intersection between metabolism and the epitranscriptome.